These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. A patient with arginase deficiency and episodic hyperammonemia successfully treated with menses cessation. Boles RG; Stone ML Mol Genet Metab; 2006 Dec; 89(4):390-1. PubMed ID: 16963300 [TBL] [Abstract][Full Text] [Related]
43. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes. Carvalho DR; Brand GD; Brum JM; Takata RI; Speck-Martins CE; Pratesi R Gene; 2012 Nov; 509(1):124-30. PubMed ID: 22959135 [TBL] [Abstract][Full Text] [Related]
44. Liver arginase activity and urea metabolism in beef heifers fed urea diets and abomasally infused with arginine and(or) ammonium acetate. Koenig JM; Bradley NW; Boling JA J Anim Sci; 1982 Feb; 54(2):426-33. PubMed ID: 7076598 [TBL] [Abstract][Full Text] [Related]
45. [Seven patients of argininemia with spastic tetraplegia as the first and major symptom and prenatal diagnosis of two fetuses with high risk]. Wu T; Li X; Ding Y; Liu Y; Song J; Wang Q; Li M; Qin Y; Yang Y Zhonghua Er Ke Za Zhi; 2015 Jun; 53(6):425-30. PubMed ID: 26310552 [TBL] [Abstract][Full Text] [Related]
46. Arginase deficiency with new phenotype and a novel mutation: contemporary summary. Tsang JP; Poon WL; Luk HM; Fung CW; Ching CK; Mak CM; Lam CW; Siu TS; Tam S; Wong VC Pediatr Neurol; 2012 Oct; 47(4):263-9. PubMed ID: 22964440 [TBL] [Abstract][Full Text] [Related]
47. Hyperargininemia: 7-month follow-up under sodium benzoate therapy in an Italian child presenting progressive spastic paraparesis, cognitive decline, and novel mutation in ARG1 gene. Baranello G; Alfei E; Martinelli D; Rizzetto M; Cazzaniga F; Dionisi-Vici C; Gellera C; Castellotti B Pediatr Neurol; 2014 Sep; 51(3):430-3. PubMed ID: 24997092 [TBL] [Abstract][Full Text] [Related]
48. AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse. Lee EK; Hu C; Bhargava R; Ponnusamy R; Park H; Novicoff S; Rozengurt N; Marescau B; De Deyn P; Stout D; Schlichting L; Grody WW; Cederbaum SD; Lipshutz GS Gene Ther; 2013 Aug; 20(8):785-96. PubMed ID: 23388701 [TBL] [Abstract][Full Text] [Related]
50. Downregulation of eNOS and preserved endothelial function in endothelial-specific arginase 1-deficient mice. Heuser SK; LoBue A; Li J; Zhuge Z; Leo F; Suvorava T; Olsson A; Schneckmann R; Guimaraes Braga DD; Srivrastava T; Montero L; Schmitz OJ; Schmitt JP; Grandoch M; Weitzberg E; Lundberg JO; Pernow J; Kelm M; Carlström M; Cortese-Krott MM Nitric Oxide; 2022 Aug; 125-126():69-77. PubMed ID: 35752264 [TBL] [Abstract][Full Text] [Related]
51. Mutations and common variants in the human arginase 1 (ARG1) gene: Impact on patients, diagnostics, and protein structure considerations. Diez-Fernandez C; Rüfenacht V; Gemperle C; Fingerhut R; Häberle J Hum Mutat; 2018 Aug; 39(8):1029-1050. PubMed ID: 29726057 [TBL] [Abstract][Full Text] [Related]
52. Current status of surviving patients with arginase 1 deficiency in Japan. Kido J; Matsumoto S; Takeshita E; Hayasaka C; Yamada K; Kagawa J; Nakajima Y; Ito T; Iijima H; Endo F; Nakamura K Mol Genet Metab Rep; 2021 Dec; 29():100805. PubMed ID: 34646736 [TBL] [Abstract][Full Text] [Related]
53. Isoenzyme pattern and immunological properties of arginase in normal and hyperargininemia fibroblasts. Konarska L; Wiesmann U; von Fellenberg R; Colombo JP Enzyme; 1983; 29(1):44-53. PubMed ID: 6404622 [TBL] [Abstract][Full Text] [Related]
54. Defective arginine metabolism impairs mitochondrial homeostasis in Caenorhabditiselegans. Tang R; Wang X; Zhou J; Zhang F; Zhao S; Gan Q; Zhao L; Wang F; Zhang Q; Zhang J; Wang G; Yang C J Genet Genomics; 2020 Mar; 47(3):145-156. PubMed ID: 32305173 [TBL] [Abstract][Full Text] [Related]
55. Argocytes containing enzyme nanoparticles reduce toxic concentrations of arginine in the blood. Kaminsky YG; Kosenko EA Bull Exp Biol Med; 2012 Jul; 153(3):406-8. PubMed ID: 22866323 [TBL] [Abstract][Full Text] [Related]
56. Strategies to rescue the consequences of inducible arginase-1 deficiency in mice. Ballantyne LL; Sin YY; St Amand T; Si J; Goossens S; Haenebalcke L; Haigh JJ; Kyriakopoulou L; Schulze A; Funk CD PLoS One; 2015; 10(5):e0125967. PubMed ID: 25938595 [TBL] [Abstract][Full Text] [Related]
57. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene. Shi O; Morris SM; Zoghbi H; Porter CW; O'Brien WE Mol Cell Biol; 2001 Feb; 21(3):811-3. PubMed ID: 11154268 [TBL] [Abstract][Full Text] [Related]
58. Treatment of arginase deficiency revisited: guanidinoacetate as a therapeutic target and biomarker for therapeutic monitoring. Amayreh W; Meyer U; Das AM Dev Med Child Neurol; 2014 Oct; 56(10):1021-4. PubMed ID: 24814679 [TBL] [Abstract][Full Text] [Related]
59. Ammonia metabolism and hyperammonemic disorders. Walker V Adv Clin Chem; 2014; 67():73-150. PubMed ID: 25735860 [TBL] [Abstract][Full Text] [Related]
60. Glutaminase 2 knockdown reduces hyperammonemia and associated lethality of urea cycle disorder mouse model. Mao X; Chen H; Lin AZ; Kim S; Burczynski ME; Na E; Halasz G; Sleeman MW; Murphy AJ; Okamoto H; Cheng X J Inherit Metab Dis; 2022 May; 45(3):470-480. PubMed ID: 34988999 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]